#news #biotech GSK, German Merck’s $4.2B bintrafusp alfa drug a bust, fails to beat king Keytruda in lung cancer

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GSK, German Merck’s $4.2B bintrafusp alfa drug a bust, fails to beat king Keytruda in lung cancer .GSK, German Merck’s $4.2B bintrafusp alfa drug a bust, fails to beat king Keytruda in lung cancer
badams
Wed, 01/20/2021 – 09:28

from FierceBiotech: Biotech https://ift.tt/39N9AQS